Vonoprazan test for acid reflux that doesn't respond to standard medicine
Part of Digestive system clinical trials.
This trial tests a medicine called vonoprazan for people whose acid reflux symptoms (like heartburn or coughing) don't get better with usual treatment. It aims to see if vonoprazan can help control those symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 75 years old
- You have ongoing acid reflux symptoms such as heartburn, chest pain, or a chronic cough despite taking standard reflux medicine for at least 8 weeks
- You had an upper endoscopy (a camera test of your stomach and esophagus) in the last year
- You are scheduled for special tests on your esophagus (manometry and pH-impedance monitoring)
- You do not have certain serious conditions like major swallowing problems, past stomach surgery, cancer, or severe kidney disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heartburn medicine called vonoprazan (10 mg) compared to a placebo (sugar pill) for people with chronic heartburn but no damage to the esophagus. If you have heartburn at least 4 days a week, you may be able to try this once-daily pill for 24 weeks.
This trial tests a newer medication called vonoprazan against the standard treatment pantoprazole for patients with gastroesophageal reflux disease (GERD). The goal is to see which one works better for controlling symptoms like heartburn and acid reflux over 8 weeks.
This trial tests vonaprazan (two doses) against esomeprazole to see which better heals moderate-to-severe reflux esophagitis (a damaged esophagus from acid reflux) in 8 weeks. You may qualify if you have had heartburn or regurgitation for at least a month and your doctor found grade B, C, or D damage on an endoscopy.
This study compares two medications, vonoprazan and esomeprazole, to see which works better for healing damage to the esophagus caused by acid reflux (erosive esophagitis). If you have this condition, this trial could help find you the most effective treatment.
This trial tests whether vonoprazan can reduce ulcers caused by a procedure that ties off enlarged veins in the esophagus (variceal band ligation). It is meant for people with liver cirrhosis who are scheduled to receive this treatment.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
Hear when a new Refractory GERD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.